Depression with Excessive Daytime Sleepiness

If you are currently feeling depressed and have a hard time staying awake during the day even after sleeping, on average, at least 6 hours per night, you may be interested in the CLARITY study.

The goal of the CLARITY study is to see if the investigational medicine, solriamfetol, is a safe and effective option for adults with major depressive disorder (MDD) with excessive daytime sleepiness (EDS). Solriamfetol is approved by the FDA for adults who have excessive daytime sleepiness due to obstructive sleep apnea (OSA) and narcolepsy, which are sleep-related disorders. Solriamfetol is an investigational treatment for MDD with EDS, meaning it has not yet been approved by any health authority for the treatment of MDD with EDS.